Bayer will sell the epigenetic saliva test developed by diagnostics provider Hurdle to measure biological age directly to consumers online.
The move is part of a strategic partnership that Bayer’s consumer health division has entered into with Hurdle in the area of personalized medicine.
“Across cultures, people want to better control their aging,” said David Evendon-Challis, chief research officer at Bayer Consumer Health. “Enabling people to better understand their own personal cellular aging process through scientific data is the first step in taking proactive steps to support that process.”
The Bayer division recently founded a new unit to develop precision health products.
The Bayer share was temporarily trading 2.24 percent lower at 30.95 euros via XETRA.
FRANKFURT (Dow Jones)
Selected leverage products on Bayer
With knock-outs, speculative investors can participate disproportionately in price movements. Simply select the lever you want and we will show you suitable open-end products on Bayer
The leverage must be between 2 and 20
Advertising